Evidence map›Paper›PMID 29272854›Full record

ArticleRedox biology2018

Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line.

Mikita Patel, Vidhush Yarlagadda, Oreoluwa Adedoyin, Vikram Saini, Dean G Assimos, Ross P Holmes, Tanecia Mitchell

Abstract read
In one paragraph

Article in Redox biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Metabolic changes in kidney stone disease.Frontiers in immunology · 2023
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Colonization withbioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Research (Washington, D.C.) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mikita PatelDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, United States.
Vidhush YarlagaddaDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, United States.
Oreoluwa AdedoyinDivision of Nephrology, University of Alabama at Birmingham, Birmingham, AL, United States.
Vikram SainiDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States.
Dean G AssimosDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, United States.
Ross P HolmesDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, United States.
Tanecia MitchellDepartment of Urology, University of Alabama at Birmingham, Birmingham, AL, United States. Electronic address: taneciam@uab.edu.

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
UAB-UCSD O'Brien Core Center for Acute Kidney Injury ResearchP30DK079337 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AGARWAL, ANUPAM · 2008 to 2022
$18.3M
Mentored Experiences in Research, Instruction and Teaching (MERIT) Program - administrative supplementK12GM088010 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHNEIDER, DAVID ALAN · 2009 to 2024
$9.2M
Mitochondrial Metabolism in Primary HyperoxaluriaR01DK054468 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HOLMES, ROSS P · 1999 to 2017
$4.1M
Monocyte Mitochondrial Dysfunction and Kidney Stone DiseaseK01DK106284 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MITCHELL, TANECIA R · 2016 to 2021
$912k
NIDDK NIH HHS K01 DK106284NIDDK NIH HHS P30 DK079337NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK054468NIGMS NIH HHS K12 GM088010
6 · The paper itself

Abstract

Monocytes/macrophages are thought to be recruited to the renal interstitium during calcium oxalate (CaOx) kidney stone disease for crystal clearance. Mitochondria play an important role in monocyte function during the immune response. We recently determined that monocytes in patients with CaOx kidney stones have decreased mitochondrial function compared to healthy subjects. The objective of this study was to determine whether oxalate, a major constituent found in CaOx kidney stones, alters cell viability, mitochondrial function, and redox homeostasis in THP-1 cells, a human derived monocyte cell line. THP-1 cells were treated with varying concentrations of CaOx crystals (insoluble form) or sodium oxalate (NaOx; soluble form) for 24h. In addition, the effect of calcium phosphate (CaP) and cystine crystals was tested. CaOx crystals decreased cell viability and induced mitochondrial dysfunction and redox imbalance in THP-1 cells compared to control cells. However, NaOx only caused mitochondrial damage and redox imbalance in THP-1 cells. In contrast, both CaP and cystine crystals did not affect THP-1 cells. Separate experiments showed that elevated oxalate also induced mitochondrial dysfunction in primary monocytes from healthy subjects. These findings suggest that oxalate may play an important role in monocyte mitochondrial dysfunction in CaOx kidney stone disease.

Indexed as

AdultCalcium PhosphatesCell LineCell SurvivalHomeostasisHumansKidneyMaleMitochondriaMonocytesNephrolithiasisOxalatesOxidation-Reductioncalcium phosphateCalcium PhosphatesOxalatesCalcium oxalateKidney stonesMitochondriaMnSODMonocytesSodium oxalate

Identifiers

PMID29272854
PMCPMC5975227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.